mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines.
Saved in:
| Title: | mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines. |
|---|---|
| Authors: | Kaplonek P; Moderna, Inc, Cambridge, MA, USA., Vargas R; Moderna, Inc, Cambridge, MA, USA., Lee JS; Moderna, Inc, Cambridge, MA, USA., Bertera H; Moderna, Inc, Cambridge, MA, USA., Astley E; Moderna, Inc, Cambridge, MA, USA.; Tufts Medical Center, Boston, MA, USA., Girard B; Moderna, Inc, Cambridge, MA, USA., Oostendorp J; Moderna, Inc, Cambridge, MA, USA., Henry C; Moderna, Inc, Cambridge, MA, USA., Paris R; Moderna, Inc, Cambridge, MA, USA., Yu WH; Moderna, Inc, Cambridge, MA, USA. wenhan.yu@modernatx.com., Alter G; Moderna, Inc, Cambridge, MA, USA.; AstraZeneca, Cambridge, MA, USA. |
| Source: | NPJ vaccines [NPJ Vaccines] 2025 Dec 15; Vol. 11 (1), pp. 19. Date of Electronic Publication: 2025 Dec 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
